Ryan Zimmerman
Stock Analyst at BTIG
(3.75)
# 849
Out of 5,182 analysts
251
Total ratings
51.14%
Success rate
7.63%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterates: Buy | $574 | $483.62 | +18.69% | 25 | Apr 22, 2026 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $85 | $71.38 | +19.08% | 8 | Apr 21, 2026 | |
| SYK Stryker | Reiterates: Buy | $397 | $329.35 | +20.54% | 20 | Apr 14, 2026 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $1.5 → $1 | $0.52 | +93.80% | 4 | Mar 31, 2026 | |
| HUMA Humacyte | Maintains: Buy | $6 → $3 | $0.70 | +325.59% | 8 | Mar 27, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $8 | $2.41 | +231.95% | 12 | Mar 26, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.84 | +63.04% | 4 | Mar 25, 2026 | |
| ALC Alcon | Reiterates: Buy | $92 | $76.43 | +20.37% | 15 | Mar 23, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | n/a | $93.04 | - | 12 | Mar 23, 2026 | |
| LNSR LENSAR | Upgrades: Buy | $10 | $5.44 | +83.82% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $24 | $13.69 | +75.31% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $24 | $16.37 | +46.61% | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $69.11 | +44.70% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $43 | $23.76 | +80.98% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $131 | $121.65 | +7.69% | 17 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $24.96 | +52.24% | 6 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $332.21 | +5.05% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $10.62 | +125.99% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.67 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.87 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $121.95 | +59.90% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.37 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $25.11 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $91.70 | +61.40% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.40 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $95.00 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $10.75 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $24.80 | +113.71% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.14 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $178.53 | +12.03% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $193.62 | +80.77% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $83.22 | +53.81% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.08 | +145.90% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.11 | +759.25% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $37.00 | - | 3 | Apr 2, 2020 |
Intuitive Surgical
Apr 22, 2026
Reiterates: Buy
Price Target: $574
Current: $483.62
Upside: +18.69%
GE HealthCare Technologies
Apr 21, 2026
Reiterates: Buy
Price Target: $85
Current: $71.38
Upside: +19.08%
Stryker
Apr 14, 2026
Reiterates: Buy
Price Target: $397
Current: $329.35
Upside: +20.54%
Xtant Medical Holdings
Mar 31, 2026
Maintains: Buy
Price Target: $1.5 → $1
Current: $0.52
Upside: +93.80%
Humacyte
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $3
Current: $0.70
Upside: +325.59%
Organogenesis Holdings
Mar 26, 2026
Reiterates: Buy
Price Target: $8
Current: $2.41
Upside: +231.95%
Spectral AI
Mar 25, 2026
Reiterates: Buy
Price Target: $3
Current: $1.84
Upside: +63.04%
Alcon
Mar 23, 2026
Reiterates: Buy
Price Target: $92
Current: $76.43
Upside: +20.37%
Zimmer Biomet Holdings
Mar 23, 2026
Downgrades: Neutral
Price Target: n/a
Current: $93.04
Upside: -
LENSAR
Mar 18, 2026
Upgrades: Buy
Price Target: $10
Current: $5.44
Upside: +83.82%
Mar 11, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $13.69
Upside: +75.31%
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $16.37
Upside: +46.61%
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $69.11
Upside: +44.70%
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $23.76
Upside: +80.98%
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $121.65
Upside: +7.69%
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $24.96
Upside: +52.24%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $332.21
Upside: +5.05%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $10.62
Upside: +125.99%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.67
Upside: -
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.87
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $121.95
Upside: +59.90%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.37
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $25.11
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $91.70
Upside: +61.40%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.40
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $95.00
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $10.75
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $24.80
Upside: +113.71%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.14
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $178.53
Upside: +12.03%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $193.62
Upside: +80.77%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $83.22
Upside: +53.81%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.08
Upside: +145.90%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.11
Upside: +759.25%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $37.00
Upside: -